FDA Hearing To Determine if Makena Is Allowed Back On The Market
The FDA will hold a hearing later this year to determine whether Makena should be removed from the market because the pregnancy drug's risks appear to outweigh its benefits.
Tag Archives: Makena
-
-
Makena, Proluton Exposure Before Birth May Increase Cancer Risks Later In Life: Study
A new study warns that Makena and similar pregnancy drugs could increase a child's risk of cancer later in life.
-
FDA Indicates Pregnancy Drug Makena Does Not Work and Should Be Removed From Market
FDA officials say they intend to remove the pregnancy drug Makena from the market, saying it is ineffective and thus puts pregnant women at risk of unnecessary drug side effects.
-
Makena Problems and Uncertain Future Leads To Removal Of Pregnancy Drug Manufacturer’s CEO
Uncertainty over Makena's future and the company's revenues has led AMAG Pharmaceuticals' CEO to step down, and has resulted in the company seeking to sell off some of its drugs.
-
Expert Panel Recommends FDA Remove Makena From Market, Since Pricey Pregnancy Drug is Ineffective
An FDA Advisory board says the pregnancy drug Makena should be pulled from the market after clinical trials indicated it failed to be effective at preventing premature births.
-
Makena Recall Urged By Public Citizen Due To Lack of Effectiveness Preventing Preterm Births
Public Citizen is calling on the FDA to require a Makena recall after the drug failed to show it was effective in preventing preterm births in a recent clinical trial.